MV-MFF: Multi-View Multi-Feature Fusion Model for Pneumonia Classification.

Pneumonia ranks among the most prevalent lung diseases and poses a significant concern since it is one of the diseases that may lead to death around the world. Diagnosing pneumonia necessitates a chest X-ray and substantial expertise to ensure accurate assessments. Despite the critical role of lateral X-rays in providing additional diagnostic information alongside frontal X-rays, they have not been widely used. Obtaining X-rays from multiple perspectives is crucial, significantly improving the precision of disease diagnosis. In this paper, we propose a multi-view multi-feature fusion model (MV-MFF) that integrates latent representations from a variational autoencoder and a ß-variational autoencoder. Our model aims to classify pneumonia presence using multi-view X-rays. Experimental results demonstrate that the MV-MFF model achieves an accuracy of 80.4% and an area under the curve of 0.775, outperforming current state-of-the-art methods. These findings underscore the efficacy of our approach in improving pneumonia diagnosis through multi-view X-ray analysis.

On the prediction of isolation, release, and decease states for COVID-19 patients: A case study in South Korea.

A respiratory syndrome COVID-19 pandemic has become a serious public health issue nowadays. The COVID-19 virus has been affecting tens of millions people worldwide. Some of them have recovered and have been released. Others have been isolated and few others have been unfortunately deceased. In this paper, we apply and compare different machine learning approaches such as decision tree models, random forest, and multinomial logistic regression to predict isolation, release, and decease states for COVID-19 patients in South Korea. The prediction can help health providers and decision makers to distinguish the states of infected patients based on their features in early intervention to take an action either by releasing or isolating the patient after the infection. The proposed approaches are evaluated using Data Science for COVID-19 (DS4C) dataset. An analysis of DS4C dataset is also provided. Experimental results and evaluation show that multinomial logistic regression outperforms other approaches with 95% in a state prediction accuracy and a weighted average F1-score of 95%.

Genetic data sharing and artificial intelligence in the era of personalized medicine based on a cross-sectional analysis of the Saudi human genome program.

The success of the Saudi Human Genome Program (SHGP), one of the top ten genomic programs worldwide, is highly dependent on the Saudi population embracing the concept of participating in genetic testing. However, genetic data sharing and artificial intelligence (AI) in genomics are critical public issues in medical care and scientific research. The present study was aimed to examine the awareness, knowledge, and attitude of the Saudi society towards the SHGP, the sharing and privacy of genetic data resulting from the SHGP, and the role of AI in genetic data analysis and regulations. Results of a questionnaire survey with 804 respondents revealed moderate awareness and attitude towards the SHGP and minimal knowledge regarding its benefits and applications. Respondents demonstrated a low level of knowledge regarding the privacy of genetic data. A generally positive attitude was found towards the outcomes of the SHGP and genetic data sharing for medical and scientific research. The highest level of knowledge was detected regarding AI use in genetic data analysis and privacy regulation. We recommend that the SHGP's regulators launch awareness campaigns and educational programs to increase and improve public awareness and knowledge regarding the SHGP's benefits and applications. Furthermore, we propose a strategy for genetic data sharing which will facilitate genetic data sharing between institutions and advance Personalized Medicine in genetic diseases' diagnosis and treatment.

DISCOVID: discovering patterns of COVID-19 infection from recovered patients: a case study in Saudi Arabia.

A respiratory syndrome COVID-19 pandemic has become a serious global concern. Still, a large number of people have been daily infected worldwide. Discovering COVID-19 infection patterns is significant for health providers towards understanding the infection factors. Current COVID-19 research works have not been attempted to discover the infection patterns, yet. In this paper, we employ an Association Rules Apriori (ARA) algorithm to discover the infection patterns from COVID-19 recovered patients' data. A non-clinical COVID-19 dataset is introduced and analyzed. A sample of recovered patients' data is manually collected in Saudi Arabia. Our manual computation and experimental results show strong associative rules with high confidence scores among males, weight above 70 kilograms, height above 160 centimeters, and fever patterns. These patterns are the strongest infection patterns discovered from COVID-19 recovered patients' data.

Prostate cancer malignancy detection and localization from mpMRI using auto-deep learning as one step closer to clinical utilization.

Automatic diagnosis of malignant prostate cancer patients from mpMRI has been studied heavily in the past years. Model interpretation and domain drift have been the main road blocks for clinical utilization. As an extension from our previous work we trained on a public cohort with 201 patients and the cropped 2.5D slices of the prostate glands were used as the input, and the optimal model were searched in the model space using autoKeras. As an innovative move, peripheral zone (PZ) and central gland (CG) were trained and tested separately, the PZ detector and CG detector were demonstrated effective in highlighting the most suspicious slices out of a sequence, hopefully to greatly ease the workload for the physicians.

Evaluation of participation and performance indicators in a breast cancer screening program in Saudi Arabia.

OBJECTIVES: To evaluate early performance indicators for breast cancer screening at the King Abdulaziz University Hospital in Saudi Arabia. METHODS: This study retrospectively evaluated data from women who underwent their first breast cancer screening program in Jeddah, Saudi Arabia between 2012 and 2019. Data on screening results were used to estimate performance indicators and generate descriptive statistics. RESULTS: Of the 16000 women invited from 2012 to 2019, a total of 1911 (11.9%) participated. The majority of women (68.8%) were between 40 and 55 years old. Based on the screening process results, 26.6%, 40.1%, 9.7%, 1.3%, 0.7%, and 5.2% of women had BI-RADS scores of R1, R2, R3, R4, R5, and R0 respectively. The remaining 16.3% did not have mammogram records. The recall rate, or the percentage of women who underwent further evaluation, was 19.9%; 18.9% underwent a biopsy procedure. In addition, 1.6% of women had cancer screen-detected, although only 0.7% were diagnosed with breast cancer. CONCLUSION: In light of the low participation and high recall rates, it is essential that the screening program utilizes performance indicators to optimize resource utilization and ensure the quality of the service provided. Additionally, a national framework and standardized performance indicators could mitigate this problem for other cancer screening programs.

Machine and Deep Learning towards COVID-19 Diagnosis and Treatment: Survey, Challenges, and Future Directions.

With many successful stories, machine learning (ML) and deep learning (DL) have been widely used in our everyday lives in a number of ways. They have also been instrumental in tackling the outbreak of Coronavirus (COVID-19), which has been happening around the world. The SARS-CoV-2 virus-induced COVID-19 epidemic has spread rapidly across the world, leading to international outbreaks. The COVID-19 fight to curb the spread of the disease involves most states, companies, and scientific research institutions. In this research, we look at the Artificial Intelligence (AI)-based ML and DL methods for COVID-19 diagnosis and treatment. Furthermore, in the battle against COVID-19, we summarize the AI-based ML and DL methods and the available datasets, tools, and performance. This survey offers a detailed overview of the existing state-of-the-art methodologies for ML and DL researchers and the wider health community with descriptions of how ML and DL and data can improve the status of COVID-19, and more studies in order to avoid the outbreak of COVID-19. Details of challenges and future directions are also provided.